pembrolizumab
merck
['pembro', 'lioi']
mpm combination of pembro + io, stat significant but clinically not what we would like ( 17.2 vs 16.13) but this combo seems better option in non epithelioid tumors : 12.3 vs 8.2. ( epithelioid ns). great effort of the canadian group!! #asco2023 #asco23 
Thoracic Oncologist and Clinical Researcher. Head of the Thoracic Oncology Clinic at INER México City, Private practice ABC Santa Fé & ONCARE. IPADE.